Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
about
Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer diseaseNeuropathology of non-Alzheimer degenerative disordersMolecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicineRisk factors for amyotrophic lateral sclerosisTDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPTTherapeutic and diagnostic challenges for frontotemporal dementiaClinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkersHyperphosphorylation as a defense mechanism to reduce TDP-43 aggregationSpreading of pathology in neurodegenerative diseases: a focus on human studiesHippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type AThe advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)The human frontal lobes and frontal network systems: an evolutionary, clinical, and treatment perspectivePrevalence, laterality, and comorbidity of hippocampal sclerosis in an autopsy sampleSelective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis.Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.Multiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra.Transgenic rat model of neurodegeneration caused by mutation in the TDP gene.Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43.Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndromeTDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism.TAR DNA-binding protein 43 in neurodegenerative disease.Dynamic changes of the phosphoproteome in postmortem mouse brains.Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsyTDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.TDP-43 is a key player in the clinical features associated with Alzheimer's diseasePhosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43.Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).TDP-43 in aging and Alzheimer's disease - a reviewAn ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution.Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness.National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseBroadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson's disease in Sardinia.Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegenerationDifferential clinicopathologic and genetic features of late-onset amnestic dementiasOn the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.Frontotemporal lobar degeneration-related proteins induce only subtle memory-related deficits when bilaterally overexpressed in the dorsal hippocampus.Incidence and extent of TDP-43 accumulation in aging human brain.
P2860
Q24634907-DD1100BA-79AA-4985-AE58-D19AC5BC4F81Q24657571-86232FA8-A149-42C9-9902-EA9DDFA533B2Q26768648-57F6BDB0-204E-4DF0-9741-195726A25663Q26827642-8CDCB38E-983E-4498-A039-23FFE4A5C072Q26851112-0BC6DAB5-FD4E-4113-A3A6-D193B6C2B0F7Q26998919-536412EB-E90F-494F-A1AA-CA0D373A3E79Q27008249-0DB71708-4245-44EE-AEAB-3CD53D4EDF5DQ27325625-7677F19B-674C-4CC3-9F15-C66DB3D245AFQ28082279-8D426396-4147-4B2E-B675-4564B7D9F681Q28250864-CE1CDF35-6C20-453F-9075-57D79E951BACQ28485924-B3A24B03-61B4-4459-897F-A19D294855A2Q28709470-CD84E5F4-487A-443B-8014-DCC28D7ED57EQ30051304-F1ECDFBD-63E7-477B-A2DE-A92ED3C9E9A5Q30541190-D5398CAB-7F73-4BD1-8A9B-F6E69BE933ACQ31082029-A99D7150-938B-4080-9579-F8BACBAEF05FQ33453702-B4A6FCA1-FA78-49FF-8624-F31C3B50D643Q33548806-25A61B13-2821-4B50-A33D-11823F4E521CQ33601762-A6E9B326-523B-4231-A4C7-B28440BDFF64Q33715607-C39DE718-9548-4A96-849E-60D0954E156BQ33830061-C20402DE-A53D-4579-8D30-59F999A83CDEQ33911422-535F419F-4966-42FA-A215-E25CF68B3135Q33941040-EB88FE6C-A045-45C3-B364-FA648CF93407Q33952409-13882A1D-02D0-4F45-A28E-ED26DF0E2A3DQ33984304-3AB92E26-BB1B-4D92-9D95-5B5E7963F874Q33992842-901BC955-1254-44CF-A08C-1FAFD484A719Q34232167-6FF8E75F-D9AF-4E0D-9450-A025B8E76643Q34448669-F5A328EA-59CA-4AEB-838A-AF96C82DC1E5Q34550595-B3E1B7C5-85CC-4CF8-8F0A-71440DD797E0Q34566756-BB8FD0F1-575A-420F-8AB9-0839E9A2A601Q34575728-3A0B5C89-F22A-42A9-A46A-8D1ABF9B1628Q34632269-1CAD7B5C-C503-4A73-9CCA-50C3918919D1Q34635272-DCB841A5-3E21-4FB8-9CAD-4919F736F4BBQ35171397-46CD3F8B-74EF-4E75-97A0-53F8B6E5400AQ35219292-67724675-A841-496B-BCBC-96EC20A91BC0Q35512201-A2DEE3B7-AB84-4416-8586-362AF8DE0150Q35545502-35AB8243-04B3-4D0C-83A1-A43B0BBBA526Q35592875-D7435E1A-212D-4386-951C-A2C6BBE0A74BQ35706615-DD195FAF-7D8F-4E29-819A-6E86CA39DD07Q35737271-1478F0A6-1514-4318-9C75-A9D097B05876Q35759384-CF8DA02E-ED83-41D9-9327-125C51566714
P2860
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
@en
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
@nl
type
label
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
@en
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
@nl
prefLabel
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
@en
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
@nl
P2093
P1476
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.
@en
P2093
Haruhiko Akiyama
Ian R A Mackenzie
Kazhuhiro Niizato
Masato Hasegawa
Mitsumoto Onaya
Shuji Iritani
Takashi Nonoka
Tetsuaki Arai
P2888
P304
P356
10.1007/S00401-008-0480-1
P577
2009-01-13T00:00:00Z